|
|
| | Azilsartan pharMaceutical interMediate Basic information |
| Product Name: | Azilsartan pharMaceutical interMediate | | Synonyms: | Methyl 3-aMino-2-(((2'-cyano-[1,1'-biphenyl]-4-yl)Methyl)aMino)benzoate;Azilsartan pharMaceutical interMediate###136304-78-4;methyl 3-amino-2-[[4-(2-cyanophenyl)phenyl]methylamino]benzoate;-cyanobiphenyl-4-yl)methyl]amino]benzoate;Candesartan Cilexetil Impurity 7;Benzoic acid, 3-amino-2-[[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]amino]-, methyl ester;Azilsartan Impurity 45;methyl 3-amino-2-(((2'-cyanobiphenyl-4-yl)methyl)amino)benzo... | | CAS: | 136304-78-4 | | MF: | C22H19N3O2 | | MW: | 357.41 | | EINECS: | | | Product Categories: | | | Mol File: | 136304-78-4.mol |  |
| | Azilsartan pharMaceutical interMediate Chemical Properties |
| Melting point | 106-110℃ | | Boiling point | 584.3±50.0 °C(Predicted) | | density | 1.27 | | pka | 4.54±0.11(Predicted) |
| | Azilsartan pharMaceutical interMediate Usage And Synthesis |
| Uses | Methyl Ester Candersartan Reduzate is an impurity of the antihypertensive drug candesartan and azilsartan. |
| | Azilsartan pharMaceutical interMediate Preparation Products And Raw materials |
|